Elizabeth R. Zell mainly investigates Incidence, Pediatrics, Epidemiology, Group B and Internal medicine. Her biological study spans a wide range of topics, including Young adult, Disease burden, Pneumonia and Intensive care medicine. Her Pediatrics study incorporates themes from Bacteremia, Disease, Surgery and Risk factor.
Her Epidemiology research includes themes of National Health Interview Survey, Cancer, Pneumococcal vaccine and Acquired immunodeficiency syndrome. The concepts of her Internal medicine study are interwoven with issues in Penicillin, Pneumococcal 7-Valent Conjugate Vaccine, Serotype and Streptococcus pneumoniae. Her study looks at the relationship between Pneumococcal conjugate vaccine and fields such as Immunology, as well as how they intersect with chemical problems.
Her primary scientific interests are in Pediatrics, Vaccination, Immunology, Incidence and Epidemiology. She interconnects Surgery, Group B, Immunization, Pneumococcal conjugate vaccine and Meningococcal disease in the investigation of issues within Pediatrics. Her work carried out in the field of Pneumococcal conjugate vaccine brings together such families of science as Serotype and Pneumococcal infections.
Elizabeth R. Zell has included themes like Pneumococcal disease, Case-control study and Family medicine in her Vaccination study. The Immunology study combines topics in areas such as Internal medicine and Risk factor. The various areas that Elizabeth R. Zell examines in her Incidence study include Meningitis, Young adult, Intensive care medicine and Disease, Disease burden.
Elizabeth R. Zell focuses on Pediatrics, Immunology, Incidence, Vaccination and Pneumococcal conjugate vaccine. Her research in Pediatrics intersects with topics in Pneumonia, Immunization, Case-control study, Rotavirus and Meningococcal disease. Her studies deal with areas such as Internal medicine and Group B as well as Immunology.
Elizabeth R. Zell combines subjects such as Young adult, Chemoprophylaxis, Epidemiology and Disease burden with her study of Incidence. Her studies in Vaccination integrate themes in fields like Odds ratio and Family medicine. Her Pneumococcal conjugate vaccine study integrates concerns from other disciplines, such as Serotype, Pneumococcal disease and Pneumococcal infections.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Invasive Methicillin-Resistant Staphylococcus aureus Infections in the United States
R. Monina Klevens;Melissa A. Morrison;Joelle Nadle;Ken Gershman.
JAMA (2007)
Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States.
Cynthia G. Whitney;Monica M. Farley;James Hadler;Lee H. Harrison.
The New England Journal of Medicine (2000)
Effect of Introduction of the Pneumococcal Conjugate Vaccine on Drug-Resistant Streptococcus pneumoniae
Moe H. Kyaw;Ruth Lynfield;William Schaffner;Allen S. Craig.
The New England Journal of Medicine (2006)
Bacterial Meningitis in the United States, 1998-2007
Michael C Thigpen;Cynthia G Whitney;Nancy E Messonnier;Elizabeth R Zell.
The New England Journal of Medicine (2011)
Epidemiology of invasive group B streptococcal disease in the United States, 1999-2005.
Christina R. Phares;Ruth Lynfield;Monica M. Farley;Janet Mohle-Boetani.
JAMA (2008)
Decline of Childhood Haemophilus influenzae Type b (Hib) Disease in the Hib Vaccine Era
W G Adams;K A Deaver;S L Cochi;B D Plikaytis.
JAMA (1993)
Active bacterial core surveillance of the emerging infections program network.
Schuchat A;Hilger T;Zell E;Farley Mm.
Emerging Infectious Diseases (2001)
Epidemiology of Invasive Streptococcus pneumoniae Infections in the United States, 1995-1998: Opportunities for Prevention in the Conjugate Vaccine Era
Katherine A. Robinson;Wendy Baughman;Gretchen Rothrock;Nancy L. Barrett.
JAMA (2001)
A Population-Based Comparison of Strategies to Prevent Early-Onset Group B Streptococcal Disease in Neonates
Stephanie J. Schrag;Elizabeth R. Zell;Ruth Lynfield;Aaron Roome.
The New England Journal of Medicine (2002)
Effect of use of 13-valent pneumococcal conjugate vaccine in children on invasive pneumococcal disease in children and adults in the USA: Analysis of multisite, population-based surveillance
Matthew R Moore;Ruth Link-Gelles;William Schaffner;Ruth Lynfield.
Lancet Infectious Diseases (2015)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
National Center for Immunization and Respiratory Diseases
Centers for Disease Control and Prevention
Emory University
Minnesota Department of Health
University of Pittsburgh
University of California, Berkeley
University of the Witwatersrand
Johns Hopkins University
Vanderbilt University
University of the Witwatersrand
The University of Texas at Austin
Stanford University
Glenn Research Center
Texas A&M University
University of Warsaw
National Evolutionary Synthesis Center
University of Massachusetts Amherst
Inserm : Institut national de la santé et de la recherche médicale
Northwestern University
University of Rennes
California Institute of Technology
Trinity College Dublin
Concordia University
University of Washington
University of Cambridge
Universität Hamburg